Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 461 (ZNF461) is a member of the C2H2-type zinc finger protein family, characterized by the presence of a zinc finger motif that facilitates DNA binding[4][1]. It is predicted to function as a nucleic acid-binding transcription factor, involved in RNA polymerase II–dependent regulation of gene expression[2][4]. While its detailed physiological role is not fully delineated, ZNF461 is active in the nucleus and is believed to contribute to transcriptional control mechanisms. Human disease associations include lung non-small cell carcinoma and disorders of sex reversal, though its precise contribution to these conditions remains undefined[2]. There are no known drugs targeting ZNF461, nor is it established as a clinical biomarker. It is a protein-coding gene with several reported isoforms; functional studies suggest that it may participate in specialized transcriptional regulation within specific tissues[2][4].
None reported; as it is not recognized as a therapeutic target, mechanisms of action for drugs are not described
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 461 (ZNF461).